Emily is an Associate Director specializing in aging and Alzheimer’s, with a focus on advancing access to emerging treatments, diagnostics, and innovations. She brings deep expertise in designing and executing global, multi-stakeholder convenings that unite leaders across the nonprofit, industry, biotech, and healthcare sectors. Her work helps clients navigate complex policy and regulatory landscapes to accelerate impact and drive meaningful change.
With a career spanning public health, nonprofit advocacy, and health tech startups, Emily brings a multidisciplinary lens to every engagement. She holds a Master of Public Health from Columbia University.